Join BOPA
Back to news articles

Community Pharmacist Jackie Lewis – recently featured in the Chemist and Druggist

By BOPA on 5th August 2022

BOPA’s pioneering Community Pharmacist Jackie Lewis recently featured in the Chemist and Druggist where her work was described critical to the recovery of cancer services post-pandemic.  Jackie is the author and project lead of Let’s Communicate Cancer, which is now  available on the NHS e-Learning for Health platform and will be key to supporting the successful pilot of direct referral of potential cancer patients identified in community pharmacy.

 

C+D Award-winning pharmacy cancer training now available nationally | Chemist+Druggist :: C+D (chemistanddruggist.co.uk)

NHS England » High street pharmacies spot cancers in new NHS early diagnosis drive

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article